NVOS (NVOS) Stock Price & Analysis
NVOS (NVOS) rose 550.00% to USD 0 as of September 8, 2026 at 14:50 UTC, according to Nexqual real-time market data.
NVOS last closed at USD 0; the session ranged USD 0.01–0.01 on volume of 1,507 shares. Market capitalization is —, with a 52-week range of USD 0–0.06 (PNK). Source: Nexqual, September 8, 2026 at 14:50 UTC.
Key Statistics (as of September 8, 2026 at 14:50 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 550.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.06 |
| Volume | 1,507 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (NVOS)
Nexqual's technical model rates NVOS "BUY" based on 4 bullish and 2 bearish signals across 126 daily candles, as of September 8, 2026 at 14:50 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.95 (neutral) |
| vs SMA50 | Above (USD 0) |
| MACD | -0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GNS | Genius Group Limited | USD 0.18 | ▼ 5.37% |
| AVTX | Avalo Therapeutics, Inc. | USD 19.89 | ▲ 4.66% |
| CRKN | Crown Electrokinetics Corp. | USD 0 | ▲ 0% |
| COSM | Cosmos Health Inc. | USD 0.27 | ▼ 0.08% |
| PXMD | PaxMedica, Inc. | USD 0 | ▼ 28.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:50 UTC. This page is informational and not investment advice.